The effects of substances extracted from Toona sinensis leaves, using 50% alcohol/water, on cellular [
Diabetes mellitus is a complex and chronic progressive disease that can eventually adversely affect the function of many organs. Most patients with type 2 diabetes mellitus exhibit hyperglycemia and peripheral insulin resistance. Current drug therapy for diabetes mellitus is aimed at improving glycemic control [1] . Despite the fact that oral hypoglycemic agents have been available for almost 30 years, their precise mode of action and role in the management of diabetes mellitus remain poorly defined and controversial [2] . The most commonly used class of oral hypoglycemics are sulfonylureas, whose mechanism of action probably involves insulin release from pancreatic -cells [3] [4] [5] . The sulfonylureas also have extrapancreatic action that help with insulin resistance in type 2 diabetes [6] . They are valuable therapeutic agents, but nevertheless, they possess disadvantages such as a reduction in efficacy and the potential to induce hypoglycemia in the long term [7] . Thus, numerous other hypoglycemic compounds, including crude drugs, have been investigated as potential agents for treating type 2 diabetes.
Recently, it was reported that ginseng extract increased glucose uptake in rabbit brain [8] and sheep erythrocytes [9] . However, protopanaxatriol ginsenosides inhibit glucose uptake in cultured renal proximal tubular cells [10] . We have previously reported that many crude drugs, including Radix asparagi and Radix ophiopogonis, increase glucose uptake in basal and insulin-stimulated 3T3-L1 adipocytes [11] .
Toona sinensis is an upland tree that is widely distributed throughout Southeast Asia. Its leaves are used as a vegetable in China and Malaysia, and the tender leaves have also been used as a carminative [12] . Although this plant has been used medicinally for a long time, its effects are not fully understood. Antiproliferative effects on human lung cancer cells have been reported recently [13] . In the present study, we evaluated the effects of substances extracted from Toona sinensis leaves, using 50% alcohol solution, on cellular glucose uptake by 3T3-L1 adipocytes. Our objective was to find new hypoglycemic compounds for potential use in patients with diabetes mellitus. 
MATERIALS AND METHODS

Materials
Differentiation of 3T3-L1 cells to adipocytes
3T3-L1 pre-adipocytes were differentiated to adipocytes as described previously by Hong et al [11] .
Briefly, 2 days after confluence (Day 0), the medium was removed and fresh medium containing 0.5 mM IBMX and 0.25 mM dexamethasone was added. After another 3 days, the medium was replaced with fresh culture medium. The cultures were then maintained as described above. By Day 8, more than 90% of the cells had differentiated into rounded cells with lipid droplets.
Measurement of glucose uptake activity
Substances were extracted from Toona sinensis leaves by boiling in 50% v/v alcohol/water for 3 hours. Following centrifugation at 2,000g for 10 minutes, the extracted substances were lyophilized. On days 8 to 12, differentiated adipocytes were incubated in serumfree medium with 1% BSA in the absence or presence of Toona sinensis leaf extract at concentrations of 0.001, 0.01, or 0.1 mg/mL at 37 C for 60 minutes. Glucose uptake was analyzed by measuring the uptake of [ 3 H]-2-deoxyglucose into cells as previously described [11] . Briefly, after treatment, cells were washed three times with Krebs-Ringer phosphate buffer containing 128 mM NaCl, 4.7 mM KCl, 1.25 mM CaCl 2 , 1.25 mM MgSO 4 , and 10 mM Na 2 HPO 4 at pH 7.4. 
Statistical analysis
Overall significant differences between groups were determined using one-way ANOVA. The least significant difference was used to determine significant differences between individual samples. Values were considered to be significantly different from the control if p was less than 0.05.
RESULTS
Basal glucose uptake was measured as 0.23 0.01 nmol/min/mg protein. Figure 1 ). The effects were dose-dependent, increasing 130%, 144%, and 165%, from the basal value.
In the presence of insulin, cellular glucose uptake was significantly increased to 0.35 0.02 nmol/min/mg protein (Figure 1 
. Dose-dependent effects of Toona sinensis (TS) leaf extract on [ 3 H]-2-deoxyglucose uptake in control and insulinstimulated 3T3-L1 adipocytes. Values are mean standard error from three experiments with triplicate determination. *p < 0.05 compared with control (n = 9).
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DISCUSSION
The results of this study demonstrated that exposure to various concentrations of Toona sinensis leaf substances extracted with 50% alcohol enhanced both basal and insulin-stimulated glucose uptake in 3T3-L1 adipocytes. There is currently little data on the effects of Toona sinensis leaf substances on glucose uptake in cultured adipocytes in vitro. The regulatory mechanism of these substances on cellular glucose uptake may be mediated by distinct mechanisms in the presence and absence of insulin, as shown by the fact that pretreatment with the protein synthesis inhibitor cycloheximide and the protein kinase C inhibitor calphostin C only inhibited enhancement of glucose uptake by Toona sinensis leaf extract in insulin-treated cells. Protein synthesis and protein kinase C may not be involved in Toona sinensis leaf extract-regulation of glucose uptake in the absence of insulin. However, the exact mechanism needs to be determined. The most commonly used oral hypoglycemic agents are the sulfonylureas, whose mechanism of action probably involves insulin release [3, 4] . More recent studies have indicated that sulfonylurea may act, in part, by increasing insulin sensitivity in extrapancreatic tissues [14, 15] . The hypoglycemic effect of drugs such as sulfonylureas is decreased gradually after longterm use. Thus, combination therapy with two or three different classes of oral antidiabetic agents is used. When maximum doses of oral antidiabetic agents do not adequately control glycemia, insulin therapy is necessary [16] . However, subcutaneous injection of insulin is inconvenient and painful for patients. It is thus important to find more convenient hypoglycemic compounds for type 2 diabetes patients. The present study shows that alcohol-extracted substances from
Toona sinensis leaves possess significant glucose uptakestimulating activity in 3T3-L1 adipocytes. Substances extracted using 50% alcohol can be easily taken orally, so are convenient for type 2 diabetes patients. Furthermore, Toona sinensis leaves are eaten as a vegetable in China and Malaysia. Although the mechanism of enhanced glucose uptake in adipocytes is uncertain, substances from Toona sinensis leaves may be used as an adjunctive antihyperglycemic agent. 3T3-L1 cells are an excellent experimental model to quickly screen the effects of crude drugs on glucose uptake. When 3T3-L1 fibroblasts grow exponentially, cells maintain the fibroblast phenotype, but when division ceases and the cells mature, as many as 20% to 40% of cells may undergo spontaneous differentiation to adipocytes over a period of 20 to 30 days [17] . The process of differentiation may be accelerated in a number of ways, for example, by increasing the amount of serum in the culture medium or by adding certain hormones or other chemical agents such as insulin, biotin, l-methyl-3-isobutylxanthine or dexamethasone to the medium. Fully differentiated 3T3-L1 adipocytes are particularly responsive to insulin, so sugar uptake can be acutely activated many fold by insulin [18] . In contrast to isolated adipocyte suspensions from animal tissues that lose cell viability rapidly, 3T3-L1 adipocytes can be studied in a stable cell monolayer that maintains cell viability and hormonal responsiveness for extended periods of time. Thus, 3T3-L1 cells are also a convenient experimental model to screen the effects of crude drugs on glucose uptake [11] . The results of this in vitro study in 3T3-L1 adipocytes may not reflect the in vivo situation. However, Toona sinensis leaves extracted with 50% alcohol solution may provide an alternative agent in the treatment of diabetes mellitus patients. 
